Reata Pharmaceuticals, Inc. (RETA) has 12 identified peers for comparison in the Healthcare sector. Peers include AKRO, CVAC, ICPT, KRYS, MDGL, MRTX and others.
RETA has a market capitalization of $6.57B, compared to an average peer market cap of $4.1B. RETA is significantly larger than its average peer.
